Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Neilan

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2023
Daily Oral HIV Pre-exposure Prophylaxis Among Young Men Who Have Sex With Men in the United States: Cost-saving at Generic Drug PriceAlyssa K Amick, G Ege Eskibozkurt, Sybil G Hosek, et al.
Medrxiv : the Preprint Server for Health Sciences|June 14, 2021
Virologic features of SARS-CoV-2 infection in childrenLael M Yonker, Julie Boucau, James Regan, et al.
The Journal of Infectious Diseases|October 14, 2021
Virologic Features of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in ChildrenLael M Yonker, Julie Boucau, James Regan, et al.
Annals of Internal Medicine|January 31, 2022
Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States : A Cost-Effectiveness AnalysisAnne M Neilan, Raphael J Landovitz, Mylinh H Le, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2020
Cost-effectiveness of Frequent HIV Screening Among High-risk Young Men Who Have Sex With Men in the United StatesAnne M Neilan, Alexander J B Bulteel, Sybil G Hosek, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|December 24, 2017
The Optimal Age for Screening Adolescents and Young Adults Without Identified Risk Factors for HIVAnne M Neilan, Richard Dunville, M Cheryl Bañez Ocfemia, et al.
The Lancet. Global Health|November 22, 2024
Cost-effectiveness of viral load testing for transitioning antiretroviral therapy-experienced children to dolutegravir in South Africa: a modelling analysisIsaac Ravi Brenner, Clare F Flanagan, Martina Penazzato, et al.
JAMA Pediatrics|March 28, 2017
Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus-Infected YouthAnne M Neilan, Brad Karalius, Kunjal Patel, et al.
Journal of the International AIDS Society|December 15, 2022
Prevalence of undiagnosed HIV among children in South Africa, Côte d'Ivoire and Zimbabwe: a model-based analysis to inform paediatric HIV screening programmesNicole C McCann, Tijana Stanic, Martina Penazzato, et al.
Medrxiv : the Preprint Server for Health Sciences|January 2, 2026
Costs associated with increasing numbers of Medicare beneficiaries with HIV aged 65 years and older from 2026 to 2035Emily P Hyle, Luke Ang, Grace Luu, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2023
Daily Oral HIV Pre-exposure Prophylaxis Among Young Men Who Have Sex With Men in the United States: Cost-saving at Generic Drug PriceAlyssa K Amick, G Ege Eskibozkurt, Sybil G Hosek, et al.
Medrxiv : the Preprint Server for Health Sciences|June 14, 2021
Virologic features of SARS-CoV-2 infection in childrenLael M Yonker, Julie Boucau, James Regan, et al.
The Journal of Infectious Diseases|October 14, 2021
Virologic Features of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in ChildrenLael M Yonker, Julie Boucau, James Regan, et al.
Annals of Internal Medicine|January 31, 2022
Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States : A Cost-Effectiveness AnalysisAnne M Neilan, Raphael J Landovitz, Mylinh H Le, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2020
Cost-effectiveness of Frequent HIV Screening Among High-risk Young Men Who Have Sex With Men in the United StatesAnne M Neilan, Alexander J B Bulteel, Sybil G Hosek, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|December 24, 2017
The Optimal Age for Screening Adolescents and Young Adults Without Identified Risk Factors for HIVAnne M Neilan, Richard Dunville, M Cheryl Bañez Ocfemia, et al.
The Lancet. Global Health|November 22, 2024
Cost-effectiveness of viral load testing for transitioning antiretroviral therapy-experienced children to dolutegravir in South Africa: a modelling analysisIsaac Ravi Brenner, Clare F Flanagan, Martina Penazzato, et al.
JAMA Pediatrics|March 28, 2017
Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus-Infected YouthAnne M Neilan, Brad Karalius, Kunjal Patel, et al.
Journal of the International AIDS Society|December 15, 2022
Prevalence of undiagnosed HIV among children in South Africa, Côte d'Ivoire and Zimbabwe: a model-based analysis to inform paediatric HIV screening programmesNicole C McCann, Tijana Stanic, Martina Penazzato, et al.
Medrxiv : the Preprint Server for Health Sciences|January 2, 2026
Costs associated with increasing numbers of Medicare beneficiaries with HIV aged 65 years and older from 2026 to 2035Emily P Hyle, Luke Ang, Grace Luu, et al.
Pageof 7